Citi Reiterates Buy Rating on Abbott Labs (ABT)

Go back to Citi Reiterates Buy Rating on Abbott Labs (ABT)

Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping

October 10, 2024 9:00 AM EDT

Enrollment completed ahead of schedule in the global IDE for Abbott's Volt PFA SystemGlobal FOCALFLEX trial now underway for Abbott's TactiFlex Duo Ablation Catheter, Sensor EnabledAdvisor HD Grid X Mapping Catheter, Sensor Enabled, receives U.S. Food and Drug Administration clearance, begins commercial launch

ABBOTT PARK, Ill., Oct. 10, 2024 /PRNewswire/ --... More